Goldan Keith A. bought SNDX
January 30, 2026 · Form 4 insider transaction
Goldan Keith A. bought 1,219 shares of Syndax Pharmaceuticals, Inc. at $8.48 per share, a transaction worth $10.3K. The trade was recorded as j and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,219
Price
$8.48
Total value
$10.3K
InsiderGoldan Keith A.
RoleOfficer
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJanuary 30, 2026
Filing dateFebruary 6, 2026
Shares owned after93,671
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,219 shares by the Reporting Person on 1/30/2026 pursuant to the Issuer's Employee Stock Purchase Plan.